GGrantIndex
← Leaderboards

Keith A Reimann

Beth Israel Deaconess Medical Center

$30,085,984
Attributed
$30,085,984
Total exposure
20
Grants
13
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $5.5M · FY200517
$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17

Funding mix

By agency

NIH$30,085,984 · 20

By mechanism

R24$11,469,630 · 2
N01$11,359,519 · 2
U24$3,405,429 · 1
R01$1,694,644 · 2
P51$1,169,489 · 12
P30$987,273 · 1

Top collaborators

No co-investigators on record.

Most similar at Beth Israel Deaconess Medical Center

Same institution · by research overlap

Others in their field

Top investigators on “Reagent

Research focus

ReagentCellsNonhuman PrimateResourcesIn VivoAnimal ModelResearch PersonnelAntibodiesUnited States National Institutes Of HealthImmune FunctionProgramsPathogenesisProductionMacaca MulattaGrantFundingIn VitroContractsBaseImmunologicsLymphocyte SubsetTechnologyCommunicable DiseasesPrimates

Grant awards (50)

Nonhuman Primate Reagent Resource$1,769,004
U24 · FY2017 · AI · contact PI
Resource fo Nonhuman Primate Cell Depleting Antibodies$649,994
R24 · FY2017 · OD · contact PI
Nonhuman Primate Reagent Resource$1,636,425
U24 · FY2016 · AI · contact PI
Resource fo Nonhuman Primate Cell Depleting Antibodies$684,206
R24 · FY2016 · OD · contact PI
NHP reagent resource for immune-mediated and infectious diseases, and transplantation research$8,275
N01 · FY2016 · AI · contact PI
NHP reagent resource for immune-mediated and infectious diseases, and transplantation research$1,271,589
N01 · FY2015 · AI · contact PI
NHP reagent resource for AIDS HIV research$538,683
N01 · FY2015 · AI · contact PI
NHP reagent resource for immune-mediated and infectious diseases, and transplantation research$1,234,959
N01 · FY2014 · AI · contact PI
Resource for Nonhuman Primate Cell Depleting Antibodies$670,790
R24 · FY2014 · OD · contact PI
NHP reagent resource for AIDS HIV research$523,026
N01 · FY2014 · AI · contact PI
Resource for Nonhuman Primate Cell Depleting Antibodies$661,541
R24 · FY2013 · OD · contact PI
Immunology$168,857
P30 · FY2013 · AI · contact PI
NHP reagent resource for immune-mediated and infectious diseases, transplantation$3,085,472
N01 · FY2012 · AI · contact PI
Resource for Nonhuman Primate Cell Depleting Antibodies$695,727
R24 · FY2012 · OD · contact PI
NHP reagent resource for AIDS/HIV rsearch$493,012
N01 · FY2012 · AI · contact PI
Immunology$183,716
P30 · FY2012 · AI · contact PI
Resource for Nonhuman Primate Cell Depleting Antibodies$695,728
R24 · FY2011 · RR · contact PI
Immunology$255,070
P30 · FY2011 · AI · contact PI
RESOURCE FOR NONHUMAN PRIMATE CELL-DEPLETING ANTIBODIES$68,415
P51 · FY2011 · RR · contact PI
Resource for Nonhuman Primate Cell Depleting Antibodies$702,756
R24 · FY2010 · RR · contact PI
Resource for Nonhuman Primate Cell Depleting Antibodies$347,988
R24 · FY2010 · RR · contact PI
Immunology$192,421
P30 · FY2010 · AI · contact PI
RESOURCE FOR NONHUMAN PRIMATE CELL-DEPLETING ANTIBODIES$65,759
P51 · FY2010 · RR · contact PI
NON-HUMAN PRIMATE REAGENT RESOURCE$4,204,503
N01 · FY2009 · AI · contact PI
Resource for Nonhuman Primate Cell Depleting Antibodies$671,459
R24 · FY2009 · RR · contact PI
Resource for Nonhuman Primate Cell Depleting Antibodies$376,171
R24 · FY2009 · RR · contact PI
Immunology$187,209
P30 · FY2009 · AI · contact PI
RESOURCE FOR NONHUMAN PRIMATE CELL-DEPLETING ANTIBODIES$64,877
P51 · FY2009 · RR · contact PI
Resource for Nonhuman Primate Cell Depleting Antibodies$651,901
R24 · FY2008 · RR · contact PI
RESOURCE FOR NONHUMAN PRIMATE CELL-DEPLETING ANTIBODIES$237,907
P51 · FY2008 · RR · contact PI
Resource for Nonhuman Primate Cell Depleting Antibodies$645,827
R24 · FY2007 · RR · contact PI
RESOURCE FOR NONHUMAN PRIMATE CELL-DEPLETING ANTIBODIES$190,552
P51 · FY2007 · RR · contact PI
Resource for Nonhuman Primate Cell Depleting Antibodies$645,745
R24 · FY2006 · RR · contact PI
A SHIV MODEL FOR EVALUATING HIV IMMUNOTHERAPIES$134,807
P51 · FY2006 · RR · contact PI
RESOURCE FOR NONHUMAN PRIMATE CELL-DEPLETING ANTIBODIES$66,311
P51 · FY2006 · RR · contact PI
A SHIV MODEL FOR EVALUATING HIV IMMUNOTHERAPIES$69,059
P51 · FY2005 · RR
RESOURCE FOR NONHUMAN PRIMATE CELL-DEPLETING ANTIBODIES$33,521
P51 · FY2005 · RR
RESOURCE FOR NONHUMAN PRIMATE CELL DEPLETING ANTIBODIES$714,503
R24 · FY2004 · RR
RESOURCE FOR NONHUMAN PRIMATE CELL-DEPLETING ANTIBODIES$35,475
P51 · FY2004 · RR
RESOURCE FOR NONHUMAN PRIMATE CELL DEPLETING ANTIBODIES$693,540
R24 · FY2003 · RR
EFFECT OF HUMORAL IMMUNE RESPONSES IN CONTROLLING PRIMARY SIV VIREMIA$101,403
P51 · FY2003 · RR
A HUMANIZED ANTI-CD4 ANTIBODY THAT BLOCKS VIRUS ENTRY INHIBITS SIV REPLICATION$101,403
P51 · FY2003 · RR
RESOURCE FOR NONHUMAN PRIMATE CELL DEPLETING ANTIBODIES$673,338
R24 · FY2002 · RR
IMMUNOLOGIC MECHANISMS CONTROLLING SIV REPLICATION$207,487
R01 · FY2002 · RR
RESOURCE FOR NONHUMAN PRIMATE CELL DEPLETING ANTIBODIES$653,728
R24 · FY2001 · RR
CHIMERIC SHIV MODEL FOR EVALUATING HIV IMMUNOTHERAPIES$417,500
R01 · FY2001 · HL
IMMUNOLOGIC MECHANISMS CONTROLLING SIV REPLICATION$352,768
R01 · FY2001 · RR
RESOURCE FOR NONHUMAN PRIMATE CELL DEPLETING ANTIBODIES$634,688
R24 · FY2000 · RR
CHIMERIC SHIV MODEL FOR EVALUATING HIV IMMUNOTHERAPIES$375,750
R01 · FY2000 · HL
IMMUNOLOGIC MECHANISMS CONTROLLING SIV REPLICATION$341,139
R01 · FY2000 · RR